SELLAS Life Sciences (SLS) Operating Margin Growth (1y) (2013 - 2022)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 3,609.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1,536.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -170.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -3,724.00
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 -163,411.00
Jun 30, 2015 40,852.00
Mar 31, 2015 22,121.00
Dec 31, 2014 -8,432.00
Sep 30, 2014 -22,679.00
Jun 30, 2014 -33,449.00
Mar 31, 2014 -24,105.00
Dec 31, 2013 -69,581.00
Sep 30, 2013 4,698.00